Subscribe

Join Us On LinkedIn

When you’ve already taken as many hits as former Goldman Sachs board member Rajat Gupta has from his involvement in the Rajaratnam insider trading case, is there anything else bad that can still happen to you? It turns out the answer to that question is a resounding yes, as the SEC took its pound of […]
Chinese officials have accused the drugmaker of orchestrating a massive bribery and corruption scheme, putting it at risk of fines and legal action, major damage to its reputation, and loss of business in a key growth market. via Could China scandal derail Glaxo? – CNNMoney
Get caught up with the Securities Docket News Wire for July 17, 2013.